AbbottTalks

By: DeviceTalks Podcast Network
  • Summary

  • Over the past few years the world has come to recognize Abbott as a company dedicated to helping people live fuller and healthier lives. In this podcast series we'll talk with the healthcare leaders, the executives, and the engineers who are working everyday to develop new technologies to help people live their best lives.
    DeviceTalks Podcast Network
    Show more Show less
Episodes
  • S3 E1 - How Abbott built AVEIR™ DR pacemakers to be smaller, leadless, and able to talk with each other
    Apr 25 2025

    AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders.

    Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next.

    Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIR™ DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2i™ (implant-to-implant) technology.

    The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives.

    Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/


    Thank you for listening to the AbbottTalks Podcast. To subscribe to the show on your favorite podcast player, click here: https://abbotttalks.castos.com/subscribe.

    Show more Show less
    1 hr and 4 mins
  • S2 E7 - Abbott’s Sundareswaran envisions TEAM-HF & earlier interventions to redefine heart failure outcomes
    Dec 17 2024

    In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions. Sundareswaran’s path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care. The conversation highlights Abbott’s CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions.

    This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/

    Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe

    Show more Show less
    57 mins
  • S2 E6 - Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity
    Oct 22 2024

    In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation. Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions. Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

    Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

    Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe

    Show more Show less
    34 mins
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about AbbottTalks

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.